Original Source(s)
Related Content
FDA Rejects Extended Dosing Intervals for Eylea HD
The agency did not agree with Regeneron’s proposal to add dosing intervals greater than every 16 weeks, the maximum interval currently indicated for aflibercept 8 mg injections.
April 24, 2025
-
2 min
Inside the Aging Eye
A comprehensive new Elsevier publication brings global expertise together to unpack how aging drives ocular structure, function, and disease
April 28, 2026
-
2 min
Lutein Supplementation May Improve Outcomes in Early AMD
Meta-analysis found statistically significant improvements, with clearest benefits in early-stage disease
May 5, 2026
-
3 min